Clinical Trials Directory

Trials / Unknown

UnknownNCT05487833

Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis

Comparison of Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis in Patients Without Diabetes

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University Medical Centre Ljubljana · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the efficacy of infusion containing insulin and infusion without insulin on reduction of triglycerides in acute hypertriglyceridemic pancreatitis

Conditions

Interventions

TypeNameDescription
BIOLOGICALinsulin5% glucose in 0.9% NaCl with 4 IU of short acting insulin per 500 ml added, infused at a rate determined by the treating physician, treatment duration: 18 hours
OTHERstandard treatmentinfusion of a balanced solution, infused at a rate determined by the treating physician, treatment duration: 18 hours

Timeline

Start date
2022-11-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2022-08-04
Last updated
2022-11-01

Source: ClinicalTrials.gov record NCT05487833. Inclusion in this directory is not an endorsement.

Insulin and Standard Management in Hypertriglyceridemic Acute Pancreatitis (NCT05487833) · Clinical Trials Directory